Ahead of the ASCO Annual Meeting, we discuss the use of germline testing and PARP inhibitors in patients with breast cancer with Jennifer K. Litton, MD.
Jennifer K. Litton, MD
Advertisement
Articles by Jennifer K. Litton, MD
Collaboration between oncologists and reproductive endocrinologists/infertility specialists not only will improve patient care, but it also will facilitate advances in the field through cooperative research and education.
Advertisement
Latest Updated Articles
- Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
Published: June 15th 2013 | Updated:
Using Germline Testing to Inform Treatment Decisions in Breast CancerPublished: May 29th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
More Global Expertise and Talent Are Needed to Administer Cell Therapies
2
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
3
Adaptive Treatment and Other Advances May Drive Radiotherapy Field Forward
4
Examining the Full Scope of Future Advancements in Radiation Oncology
5
